Helene Duret
- Physiology top 1%
- Adenosine and Purinergic Signaling 1
- Immunology top 2%
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 6
- IL-33, ST2, and ILC Pathways 3
- T-cell and B-cell Immunology 3
- Oncology top 5%
- CAR-T cell therapy research 5
- Cancer Immunotherapy and Biomarkers 3
-
- Inflammasome and immune disorders 2
- Co-authors
- Mark J. SmythMichele W.L. TengUpulie DivisekeraJohn StaggSherene LoiStephen R. MattarolloShin Foong NgiowYuting Ma
- Cited by
- PhysiologyImmunologyOncology
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Blood (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- AustraliaFranceUnited States
In The Last Decade
Helene Duret
15 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 77
- Physiology 239
- Immunology 994
- Oncology 911
- Radiology, Nuclear Medicine and Imaging 136
- Cancer Research 83
Countries citing papers authored by Helene Duret
This map shows the geographic impact of Helene Duret's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helene Duret with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helene Duret more than expected).
Fields of papers citing papers by Helene Duret
This network shows the impact of papers produced by Helene Duret. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helene Duret. The network helps show where Helene Duret may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Helene Duret, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | CD3(bright) signals on gamma delta T cells identify IL-17A-producing V gamma 6V delta 1( ) T cells | 2015 | 2 |
| 2 | 2014 | 65 | |
| 3 | 2014 | 21 | |
| 4 | 2013 | 117 | |
| 5 | 2012 | 155 | |
| 6 | 2012 | 88 | |
| 7 | 2012 | 8 | |
| 8 | 2012 | 40 | |
| 9 | 2012 | 42 | |
| 10 | 2012 | 61 | |
| 11 | 2011 | 256 | |
| 12 | 2011 | 320 | |
| 13 | 2011 | 44 | |
| 14 | 2011 | 381 | |
| 15 | 抗IL-23単クローン抗体は標的療法または IL-2との併用で相乗作用を示し,腫瘍増殖と転移を抑制する | 2011 | 1 |
About Helene Duret
Helene Duret is a scholar working on Immunology, Oncology and Physiology, having authored 15 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (5 papers), IL-33, ST2, and ILC Pathways (3 papers), T-cell and B-cell Immunology (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Inflammasome and immune disorders (2 papers) and Adenosine and Purinergic Signaling (1 paper). The work is most often cited by research in Physiology (239 citations), Immunology (994 citations) and Oncology (911 citations). Helene Duret has collaborated with scholars based in Australia, France and United States. Frequent co-authors include Mark J. Smyth, Michele W.L. Teng, Upulie Divisekera, John Stagg, Sherene Loi, Stephen R. Mattarollo, Shin Foong Ngiow, Yuting Ma, Laurence Zitvogel and Hideo Yagita∥. Their work appears in journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.